Overview
Gareth Lema is an Ophthalmologist in New York, New York. Dr. Lema is highly rated in 10 conditions, according to our data. His top areas of expertise are Retinal Artery Occlusion, Age-Related Macular Degeneration (ARMD), Retinal Detachment, Late-Onset Retinal Degeneration, and Vitrectomy.
His clinical research consists of co-authoring 24 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1 Gustave L Levy Pl, New York, NY 10029
17 E 102nd St Fl 8, New York, NY 10029
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
David S Chu MD
Mark Kupersmith is an Ophthalmologist in New York, New York. Dr. Kupersmith is highly rated in 52 conditions, according to our data. His top areas of expertise are Papilledema, Increased Intracranial Pressure, Pseudotumor Cerebri Syndrome, Optic Neuritis, and Thymectomy.
New York Eye Surgery Associates PLLC
Nathan Radcliffe is an Ophthalmologist in Bronx, New York. Dr. Radcliffe is highly rated in 36 conditions, according to our data. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Cataract, Trabeculectomy, and Cataract Removal.
Mount Sinai Neuro-Ophthalmology At Center For Advanced Medicine Building
Louis Pasquale is an Ophthalmologist in New York, New York. Dr. Pasquale is highly rated in 10 conditions, according to our data. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Hormone Replacement Therapy (HRT).
Frequently Asked Questions about Dr. Gareth Lema
How do I make an appointment with Dr. Gareth Lema?
You can book an appointment with Dr. Gareth Lema by calling their office at 212-241-0939. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Gareth Lema a top-rated expert for Retinal Artery Occlusion?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Gareth Lema is classified as an Distinguished expert for Retinal Artery Occlusion, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Gareth Lema specialize in?
While Dr. Gareth Lema is a Ophthalmology, they have specific expertise in Retinal Artery Occlusion, Age-Related Macular Degeneration (ARMD), and Retinal Detachment. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.
Does Dr. Gareth Lema participate in research or clinical trials?
Yes. Dr. Gareth Lema has published 24 articles and abstracts on conditions like Retinal Artery Occlusion. You can view a list of Dr. Gareth Lema's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Gareth Lema accept my insurance?
Dr. Gareth Lema accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 212-241-0939 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Age-Related Macular Degeneration (ARMD)Dr. Lema isDistinguished. Learn about Age-Related Macular Degeneration (ARMD).
- Late-Onset Retinal DegenerationDr. Lema isDistinguished. Learn about Late-Onset Retinal Degeneration.
- Retinal Artery OcclusionDr. Lema isDistinguished. Learn about Retinal Artery Occlusion.
- Retinal DetachmentDr. Lema isDistinguished. Learn about Retinal Detachment.
- Advanced
- CataractDr. Lema isAdvanced. Learn about Cataract.
- Diabetic RetinopathyDr. Lema isAdvanced. Learn about Diabetic Retinopathy.
- EndophthalmitisDr. Lema isAdvanced. Learn about Endophthalmitis.
- Gyrate Atrophy of the Choroid and Retina
- Kallikrein HypertensionDr. Lema isAdvanced. Learn about Kallikrein Hypertension.
- Retinal Vein OcclusionDr. Lema isAdvanced. Learn about Retinal Vein Occlusion.
- Experienced
- Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE)
- Adult-Onset Vitelliform Macular Dystrophy (AVMD)
- Allergic ConjunctivitisDr. Lema isExperienced. Learn about Allergic Conjunctivitis.
- Bietti Crystalline Dystrophy (BCD)Dr. Lema isExperienced. Learn about Bietti Crystalline Dystrophy (BCD).
- BlepharitisDr. Lema isExperienced. Learn about Blepharitis.
- Central Serous ChorioretinopathyDr. Lema isExperienced. Learn about Central Serous Chorioretinopathy.